These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36333414)

  • 1. iPSC-neural crest derived cells embedded in 3D printable bio-ink promote cranial bone defect repair.
    Glaeser JD; Bao X; Kaneda G; Avalos P; Behrens P; Salehi K; Da X; Chen A; Castaneda C; Nakielski P; Jiang W; Tawackoli W; Sheyn D
    Sci Rep; 2022 Nov; 12(1):18701. PubMed ID: 36333414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural crest-derived mesenchymal progenitor cells enhance cranial allograft integration.
    Glaeser JD; Behrens P; Stefanovic T; Salehi K; Papalamprou A; Tawackoli W; Metzger MF; Eberlein S; Nelson T; Arabi Y; Kim K; Baloh RH; Ben-David S; Cohn-Schwartz D; Ryu R; Bae HW; Gazit Z; Sheyn D
    Stem Cells Transl Med; 2021 May; 10(5):797-809. PubMed ID: 33512772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Craniofacial Bone Regeneration Capacities of Mesenchymal Stem Cells Derived from Human Neural Crest Stem Cells and Bone Marrow.
    Srinivasan A; Teo N; Poon KJ; Tiwari P; Ravichandran A; Wen F; Teoh SH; Lim TC; Toh YC
    ACS Biomater Sci Eng; 2021 Jan; 7(1):207-221. PubMed ID: 33455206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects.
    Sheyn D; Ben-David S; Shapiro G; De Mel S; Bez M; Ornelas L; Sahabian A; Sareen D; Da X; Pelled G; Tawackoli W; Liu Z; Gazit D; Gazit Z
    Stem Cells Transl Med; 2016 Nov; 5(11):1447-1460. PubMed ID: 27400789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenic differentiation and bone regeneration of iPSC-MSCs supported by a biomimetic nanofibrous scaffold.
    Xie J; Peng C; Zhao Q; Wang X; Yuan H; Yang L; Li K; Lou X; Zhang Y
    Acta Biomater; 2016 Jan; 29():365-379. PubMed ID: 26441129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
    Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
    Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
    Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH
    Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sema3A and HIF1α co-overexpressed iPSC-MSCs/HA scaffold facilitates the repair of calvarial defect in a mouse model.
    Li J; Wang T; Li C; Wang Z; Wang P; Zheng L
    J Cell Physiol; 2020 Oct; 235(10):6754-6766. PubMed ID: 32012286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
    Xu M; Shaw G; Murphy M; Barry F
    Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation.
    Kong Y; Zhao Y; Li D; Shen H; Yan M
    J Biomed Mater Res A; 2019 Oct; 107(10):2282-2295. PubMed ID: 31152570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endochondral Bone Tissue Engineering Using Human Induced Pluripotent Stem Cells.
    Arakura M; Lee SY; Fukui T; Oe K; Takahara S; Matsumoto T; Hayashi S; Matsushita T; Kuroda R; Niikura T
    Tissue Eng Part A; 2022 Feb; 28(3-4):184-195. PubMed ID: 34309415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process.
    Hua Z; Li S; Liu Q; Yu M; Liao M; Zhang H; Xiang X; Wu Q
    Front Bioeng Biotechnol; 2022; 10():841778. PubMed ID: 35656194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and characterization of putative craniofacial mesenchymal progenitor cells from human induced pluripotent stem cells.
    Jamal M; Lewandowski SL; Lawton ML; Huang GT; Ikonomou L
    Stem Cell Res; 2018 Dec; 33():100-109. PubMed ID: 30340089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Zhong S; He X; Li Y; Lou X
    Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells.
    Claeys L; Zhytnik L; Ventura L; Wisse LE; Eekhoff EMW; Pals G; Bravenboer N; Heine VM; Micha D
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenic Differentiation Potential of Human Bone Marrow and Amniotic Fluid-Derived Mesenchymal Stem Cells in Vitro & in Vivo.
    Mohammed EEA; El-Zawahry M; Farrag ARH; Aziz NNA; Sharaf-ElDin W; Abu-Shahba N; Mahmoud M; Gaber K; Ismail T; Mossaad MM; Aleem AKA
    Open Access Maced J Med Sci; 2019 Feb; 7(4):507-515. PubMed ID: 30894903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 3A-hypoxia inducible factor 1 subunit alpha co-overexpression enhances the osteogenic differentiation of induced pluripotent stem cells-derived mesenchymal stem cells in vitro.
    Li JY; Wang TT; Li C; Wang ZF; Li S; Ma L; Zheng LL
    Chin Med J (Engl); 2020 Feb; 133(3):301-309. PubMed ID: 31929360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
    Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
    Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
    Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
    Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-765 inhibits the osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting BMP6 via regulating the BMP6/Smad1/5/9 signaling pathway.
    Wang T; Zhang C; Wu C; Liu J; Yu H; Zhou X; Zhang J; Wang X; He S; Xu X; Ma B; Che X; Li W
    Stem Cell Res Ther; 2020 Feb; 11(1):62. PubMed ID: 32059748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.